FHTX peer analysis
Foghorn Therapeutics (FHTX) against its competitors: price, today's move, 1-year return and market value side by side.
- FHTX's peers: ARCT (Arcturus), ASMB (Assembly Biosciences), ENTA (Enanta Pharmaceuticals), HUMA (Humacyte), IMRX (Immuneering), PYXS (Pyxis Oncology), SGMT (Sagimet Biosciences), TRDA (Entrada Therapeutics).
FHTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARCT Arcturus | $7.55 | -0.66% | 25.00% | $217.61M |
| ASMB Assembly Biosciences | $22.19 | -1.38% | -41.61% | $454.39M |
| ENTA Enanta Pharmaceuticals | $7.62 | -4.51% | -37.18% | $221.94M |
| HUMA Humacyte | $0.46 | -14.97% | -60.57% | $128.15M |
| IMRX Immuneering | $3.33 | -3.48% | -53.56% | $215.66M |
| PYXS Pyxis Oncology | $1.81 | 7.74% | -60.39% | $216.49M |
| SGMT Sagimet Biosciences | $9.07 | -5.72% | 15.54% | $647.31M |
| TRDA Entrada Therapeutics | $4.20 | -9.48% | -51.89% | $164.43M |
| VNDA Vanda Pharmaceuticals | $3.46 | -5.72% | -32.68% | $209.23M |
| ZURA Zura Bio | $0.93 | -2.34% | -75.97% | $89.59M |
| FHTX Foghorn Therapeutics | $1.66 | -6.74% | -65.84% | $99.54M |